Search results for "Contrast agent"

showing 10 items of 36 documents

Cecal trap: CT findings of isolated cecal necrosis

2016

Learning objectives Background Findings and procedure details Conclusion Personal information References

genetic structuresGastrointestinal tractIschaemia / InfarctioneducationAbdomenEmergencyCT cecal necrosisAcuteContrast agent-intravenousSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCT
researchProduct

Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent

2021

Purpose: The purpose of this study was to compare the value of contrast-enhanced computed tomography (CT) to that of magnetic resonance imaging obtained with extracellular contrast agent (ECA-MRI) for the diagnosis of a tumor capsule in hepatocellular carcinoma (HCC) using histopathologic findings as the standard of reference. Materials and methods: This retrospective study included patients with pathologically-proven resected HCCs with available preoperative contrast-enhanced CT and ECA-MRI examinations. Two blinded radiologists independently reviewed contrast-enhanced CT and ECA-MRI examinations to assess the presence of an enhancing capsule. The histopathological analysis of resected spe…

Gadolinium DTPAMaleCarcinoma HepatocellularContrast MediaComputed tomographySensitivity and SpecificityMcNemar's testExtracellularmedicineHumansRadiology Nuclear Medicine and imagingCapsule Computed tomography Extracellular contrast agent Hepatocellular carcinoma Magnetic resonance imagingAgedRetrospective StudiesRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver NeoplasmsCapsuleMagnetic resonance imagingRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingHepatocellular carcinomaFemaleTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessNuclear medicineKappaDiagnostic and Interventional Imaging
researchProduct

SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media

2020

Abstract Hypersensitivity reactions (HRs) to contrast media (CM) can be distinguished in immune-mediated (including allergic reactions) and non-immune-mediated reactions, even if clinical manifestations could be similar. Such manifestations range from mild skin eruptions to severe anaphylaxis, making it important for radiologists to know how to identify and manage them. A panel of experts from the Società Italiana di Radiologia Medica e Interventistica (SIRM) and the Società Italiana di Allergologia, Asma e Immunologia Clinica (SIAAIC) provided a consensus document on the management of patients who must undergo radiological investigations with CM. Consensus topics included: the risk stratif…

lcsh:Immunologic diseases. Allergyradiologic contrast media; hypersensitivity reactions; low-osmolar contrast agents; diagnosis; managementmedicine.medical_specialtyAllergyHypersensitivity reactionsReferralImmunologyReviewCulpritRadiologic contrast media03 medical and health sciences0302 clinical medicineDiagnosisHypersensitivity reactionmedicineImmunology and AllergyMedical historyIn patientLow-osmolar contrast agentsIntensive care medicineMolecular Biologybusiness.industryLow-osmolar contrast agentmedicine.diseaseManagement030228 respiratory systemRadiological weaponPremedicationbusinesslcsh:RC581-607AnaphylaxisDiagnosi030215 immunologyClinical and Molecular Allergy
researchProduct

Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients

2009

Purpose: to evaluate the role of contrast-enhanced ultrasound (CEUS) in the characterization of focal liver lesions (FLLs) for surgical patients selection. Materials and Methods: 135 consecutive patients (71 women, 64 men) with 165 FLLs (mean size: 3.1 cm) - 89 benign (10 simple cysts, 26 hemangiomas, 29 focal nodular hyperplasia (FNH), 2 hepatocellular adenomas, 11 focal fatty sparing, 3 focal fatty areas, 5 regenerative nodules, 2 hydatid cysts, 1 abscess) and 76 malignant - 47 metastases, 26 hepatocellular carcinomas and 3 peripheral cholangiocarcinomas - underwent CEUS after the administration of SonoVue®. Two readers reviewed in consensus baseline US and CEUS scans obtained 25-30 s (ar…

contrast-enhanced ultrasound liver neoplasm ultrasonographic contrast agentSettore MED/18 - Chirurgia GeneraleSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Regression of benign hepatic lesions associated with exogenous estrogens withdrawal

2014

Learning objectives Background Findings and procedure details Conclusion Personal information References

genetic structuresLivereducationAbdomenOutcomesMROutcomes Contrast agent-intravenous MR Liver AbdomenContrast agent-intravenous
researchProduct

Highly Loaded Semipermeable Nanocapsules for Magnetic Resonance Imaging.

2017

Magnetic resonance imaging has become an essential tool in medicine for the investigation of physiological processes. The key issues related to contrast agents, i.e., substances that are injected in the body for imaging, are the efficient enhancement of contrast, their low toxicity, and their defined biodistribution. Polyurea nanocapsules containing the gadolinium complex Gadobutrol as a contrast agent in high local concentration and high relaxivity up to 40 s-1 mmol-1 L are described. A high concentration of the contrast agent inside the nanocapsules can be ensured by increasing the crystallinity in the shell of the nanocapsules. Nanocapsules from aliphatic polyurea are found to display hi…

BiodistributionPolymers and PlasticsPolymersGadoliniumMRI contrast agentchemistry.chemical_elementContrast MediaBioengineeringGadolinium02 engineering and technology010402 general chemistry01 natural sciencesNanocapsulesGadobutrolBiomaterialschemistry.chemical_compoundCrystallinityMiceNanocapsulesMaterials ChemistrymedicineOrganometallic CompoundsAnimalsHumansTissue DistributionPolyureaMesenchymal Stem CellsDendrites021001 nanoscience & nanotechnologyMagnetic Resonance Imaging0104 chemical scienceschemistryLiverNanocarriers0210 nano-technologySpleenBiotechnologyBiomedical engineeringmedicine.drugMacromolecular bioscience
researchProduct

[Gadolinium-containing contrast agents: Gadoterat-meglumine is safe in patients with chronic renal failure].

2014

Objective To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-enhanced magnetic resonance imaging (MRI) to a control group (unenhanced MRI) in high-risk patients. Methods Patients with chronic kidney disease (CKD) scheduled for MRI procedures were screened. The primary endpoint was the percentage of patients with an elevation of serum creatinine levels, measured 72 ± 24 h after the MRI procedure, by at least 25 % or 44.2 μmol/l (0.5 mg/dl) from baseline. A non-inferiority margin of the between-group difference was set at −15 % for statistical analysis of the primary endpoint. Main secondary endpoints were the variation in serum creatinine and eGFR values between base…

MaleDrug-Related Side Effects and Adverse ReactionsContrast MediaAcute Kidney InjuryMeglumine gadoterateMagnetic Resonance ImagingNephrogenic Fibrosing DermopathyHeterocyclic CompoundsGd-DOTANephrogenic systemic fibrosisOrganometallic CompoundsHumansFemaleRenal Insufficiency ChronicGadolinium-based contrast agent-induced nephropathyMRIRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
researchProduct

Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound

2009

OBJECTIVE. The purpose of this study was to evaluate the effectiveness of contrast-enhanced sonography in comparison with conventional sonography in differentiating muscle- infiltrating and superficial neoplasms of the urinary bladder. SUBJECTS AND METHODS. Conventional and contrast-enhanced sonography were performed on 34 consecutively registered patients with bladder tumors. All examinations were reviewed by two independent sonologists. At gray-scale sonography, interruption of the hyperechoic bladder wall was considered the main diagnostic criterion for differentiating superficial and infiltrating tumors. At contrast-enhanced sonography, a tumor was considered superficial when the hypoen…

MalePathologymedicine.medical_specialtytumorUrinary systemcontrast agent; staging; tumor; ultrasonography; ultrasound; urinary bladderContrast MediaDiagnosis DifferentialImage Interpretation Computer-AssistedBladder tumorMedicineHumansRadiology Nuclear Medicine and imagingNeoplasm InvasivenessAgedNeoplasm StagingUrinary bladdermedicine.diagnostic_testbusiness.industryultrasoundUltrasoundGeneral MedicineCystoscopyCystoscopystagingultrasonographyMiddle Agedcontrast agentmedicine.diseaseBladder tumor stagingGray scale ultrasoundmedicine.anatomical_structureROC CurveUrinary Bladder NeoplasmsFemaleRadiologyDifferential diagnosisbusinessInfiltration (medical)urinary bladder
researchProduct

Splenic Graulomatosis

2015

Learning objectives Background Findings and procedure details Conclusion Personal information References

Inflammationgenetic structureseducationUltrasoundAbdomenSplenic GranulomatosisTissue characterisationMRInfectionContrast agent-intravenousSettore MED/36 - Diagnostica Per Immagini E RadioterapiaSpleenCT
researchProduct

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization

2016

International audience; Many studies have been devoted to adapting the design of gold nanoparticles to efficiently exploit their promising capability to enhance the effects of radiotherapy. In particular, the addition of magnetic resonance imaging modality constitutes an attractive strategy for enhancing the selectivity of radiotherapy since it allows the determination of the most suited delay between the injection of nanoparticles and irradiation. This requires the functionalization of the gold core by an organic shell composed of thiolated gadolinium chelates. The risk of nephrogenic systemic fibrosis induced by the release of gadolinium ions should encourage the use of macrocyclic chelat…

BiodistributiontumorMaterials scienceGadoliniumchemistry.chemical_elementNanoparticleContext (language use)Nanotechnology02 engineering and technology[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciences[ CHIM ] Chemical Sciencesnephrogenic systemic fibrosis[CHIM]Chemical SciencesGeneral Materials ScienceChelationratbiodistributionradiotherapyrenal clearance[ CHIM.THER ] Chemical Sciences/Medicinal Chemistry021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical scienceschemistrymri contrast agentsColloidal goldSurface modification0210 nano-technologySelectivitydihydrolipoic acidmicrobeam radiation-therapy9l gliosarcoma
researchProduct